Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 12/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.68 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.61 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.40 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8386987 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL8961324 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL8384728 | 0.98 | LPAR3 (0.64) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL8388120 | 0.91 | LPAR3 (0.57) | LPAR3LPAR2LPAR1ENPP2MPI | |
| SCHEMBL27317200 | 0.84 | LPAR3 (0.50) | LPAR3LPAR2LPAR1 | |
| SCHEMBL28124639 | 0.83 | LPAR3 (0.76) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL27042238 | 0.83 | LPAR3 (0.76) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL6033633 | 0.83 | LPAR3 (0.76) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL6851142 | 0.83 | LPAR3 (0.76) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL9233772 | 0.83 | LPAR3 (0.76) | LPAR3LPAR2LPAR1LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024092274-A2 | ENDOCYTIC AGENTS | BIOVENTURES, LLC (US) | 2024-05-02 | — | — | WO | disclosed |